Tag:

DLVR Therapeutics

Latest Headlines

DLVR Therapeutics grabs $2M in seed support, advancing nanoparticle delivery

October 25, 2011

A new player in the nanoparticle drug-delivery game has arrived. Toronto-based DLVR Therapeutics raised seed funds from MaRS Innovation, bringing the upstart's total seed support to $2 million and

THE LIBRARY: EBOOK

Supplying Global Clinical Trials: Keys to Avoiding Costly Delays

| Sponsored by Catalent

This FierceBiotech eBook provides expert analysis and industry insights to guide biopharma professionals that face the challenges of meeting strict timelines, selecting contractors and avoiding setbacks during the planning and execution of manufacturing partnerships for global clinical trials. Download Now.

MORE ITEMS

EVENTS

Don't miss an Exclusive Executive Breakfast at BIO 2012!June 19, 2012 — Boston, MA

MORE EVENTS

Press Releases

iPierian Appoints Pamela B. Conley as Vice President of Research
iPierian Advances Monoclonal Antibody Drug Development Programs Targeting Tau Protein and the Complement System for the Treatment of Neurodegenerative Diseases
PneumRx, Inc. Acquires Key Assets From Broncus
BIOTRONIK Announces Positive Results for the Passeo-18 Lux Peripheral Vascular Paclitaxel Releasing Balloon
Landmark Sleep Apnea, Heart Failure Study Recruits 1,000th Participant
More Press Releases

DLVR Therapeutics

Latest Headlines

Latest Headlines